arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

CENTENE CORP

CNC
$61.92 ▼ -0.17 (-0.27%) at close
Healthcare ·Hospital & Medical Service Plans ·USHospital & Medical Service Plans
19 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
24
Health
Poor
Bearish
auto_awesome

Analytical Summary

CENTENE CORP faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $30.5B
Dividend Yield —
Revenue Growth 19.4% ↗
Op. Margin -3.9% ↘
ROIC -20.2% ↘
FCF / Share $8.76 ↗
Trailing P/E —
Price / Book 1.5x
FCF Yield 14.2%
Debt / Equity 0.88
info Valuation on last close. End-of-day price, Sep 24, 2026.

19-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$194.78B
↑ +19.4% —
Net Income Profit after all expenses
$-6.67B
↓ -301.9% —
Operating Margin Operating profit as % of sales
-3.9%
↓ -301.0% 21th
FCF / Share Free cash flow per share
$8.76
↑ +1033.1% —
Long-Term Debt Long-term obligations
$17.49B
↓ -6.2% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
26
Returns
22
Financial Health ↑
31
Cash Quality
12

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 19 years · 72 quarters